nodes	percent_of_prediction	percent_of_DWPC	metapath
Exemestane—CYP19A1—uterine cancer	0.379	1	CbGaD
Exemestane—Dydrogesterone—Medroxyprogesterone Acetate—uterine cancer	0.0835	0.19	CrCrCtD
Exemestane—Formestane—Progesterone—uterine cancer	0.0767	0.174	CrCrCtD
Exemestane—Dydrogesterone—Progesterone—uterine cancer	0.0728	0.166	CrCrCtD
Exemestane—Testolactone—Progesterone—uterine cancer	0.0479	0.109	CrCrCtD
Exemestane—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.0427	0.0971	CrCrCtD
Exemestane—Methylprednisolone—Medroxyprogesterone Acetate—uterine cancer	0.0427	0.0971	CrCrCtD
Exemestane—Testosterone—Progesterone—uterine cancer	0.0372	0.0846	CrCrCtD
Exemestane—Prednisolone—Progesterone—uterine cancer	0.0365	0.0828	CrCrCtD
Exemestane—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0233	0.463	CbGbCtD
Exemestane—CYP3A4—Progesterone—uterine cancer	0.0155	0.307	CbGbCtD
Exemestane—CYP19A1—corpus luteum—uterine cancer	0.0119	0.541	CbGeAlD
Exemestane—CYP3A4—Etoposide—uterine cancer	0.00692	0.137	CbGbCtD
Exemestane—CYP19A1—semen—uterine cancer	0.00557	0.254	CbGeAlD
Exemestane—CYP3A4—Doxorubicin—uterine cancer	0.00472	0.0936	CbGbCtD
Exemestane—CYP19A1—endometrium—uterine cancer	0.00092	0.0419	CbGeAlD
Exemestane—CYP19A1—uterus—uterine cancer	0.000848	0.0386	CbGeAlD
Exemestane—Dydrogesterone—PGR—uterine cancer	0.000847	0.262	CrCbGaD
Exemestane—CYP19A1—female reproductive system—uterine cancer	0.000762	0.0347	CbGeAlD
Exemestane—CYP19A1—female gonad—uterine cancer	0.000694	0.0316	CbGeAlD
Exemestane—Testolactone—CYP19A1—uterine cancer	0.000471	0.146	CrCbGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—SRD5A2—uterine cancer	0.00047	0.0992	CbGpPWpGaD
Exemestane—CYP3A4—renal system—uterine cancer	0.000462	0.021	CbGeAlD
Exemestane—CYP19A1—lymph node—uterine cancer	0.000446	0.0203	CbGeAlD
Exemestane—Estropipate—ESR2—uterine cancer	0.000439	0.136	CrCbGaD
Exemestane—CYP3A4—female reproductive system—uterine cancer	0.00037	0.0168	CbGeAlD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—STAR—uterine cancer	0.00034	0.0717	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—AKR1B1—uterine cancer	0.00034	0.0717	CbGpPWpGaD
Exemestane—Conjugated Estrogens—ESR2—uterine cancer	0.000274	0.0846	CrCbGaD
Exemestane—Estrone—ESR2—uterine cancer	0.000273	0.0843	CrCbGaD
Exemestane—CYP19A1—Endogenous sterols—CYP11A1—uterine cancer	0.000271	0.0573	CbGpPWpGaD
Exemestane—Estropipate—ESR1—uterine cancer	0.00027	0.0835	CrCbGaD
Exemestane—Testosterone—CYP11A1—uterine cancer	0.000215	0.0664	CrCbGaD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—uterine cancer	0.000206	0.0434	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP11A1—uterine cancer	0.000203	0.0429	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—MLH1—uterine cancer	0.000202	0.0427	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—PGR—uterine cancer	0.000192	0.0405	CbGpPWpGaD
Exemestane—CYP19A1—Ovarian Infertility Genes—ESR2—uterine cancer	0.000169	0.0356	CbGpPWpGaD
Exemestane—Conjugated Estrogens—ESR1—uterine cancer	0.000169	0.0521	CrCbGaD
Exemestane—Estrone—ESR1—uterine cancer	0.000168	0.052	CrCbGaD
Exemestane—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—uterine cancer	0.000158	0.0334	CbGpPWpGaD
Exemestane—Body temperature increased—Progesterone—uterine cancer	0.00015	0.00149	CcSEcCtD
Exemestane—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00015	0.00148	CcSEcCtD
Exemestane—Myocardial infarction—Etoposide—uterine cancer	0.00015	0.00148	CcSEcCtD
Exemestane—Neuropathy peripheral—Etoposide—uterine cancer	0.00015	0.00148	CcSEcCtD
Exemestane—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000149	0.00147	CcSEcCtD
Exemestane—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000149	0.00147	CcSEcCtD
Exemestane—Malaise—Dactinomycin—uterine cancer	0.000149	0.00147	CcSEcCtD
Exemestane—Influenza like illness—Epirubicin—uterine cancer	0.000148	0.00147	CcSEcCtD
Exemestane—Bone pain—Doxorubicin—uterine cancer	0.000148	0.00146	CcSEcCtD
Exemestane—Leukopenia—Dactinomycin—uterine cancer	0.000147	0.00146	CcSEcCtD
Exemestane—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000147	0.00146	CcSEcCtD
Exemestane—Hepatobiliary disease—Etoposide—uterine cancer	0.000144	0.00143	CcSEcCtD
Exemestane—Neuropathy—Epirubicin—uterine cancer	0.000144	0.00142	CcSEcCtD
Exemestane—Musculoskeletal pain—Doxorubicin—uterine cancer	0.000143	0.00142	CcSEcCtD
Exemestane—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000142	0.0014	CcSEcCtD
Exemestane—Pulmonary embolism—Doxorubicin—uterine cancer	0.000141	0.0014	CcSEcCtD
Exemestane—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000141	0.00139	CcSEcCtD
Exemestane—Myalgia—Dactinomycin—uterine cancer	0.00014	0.00139	CcSEcCtD
Exemestane—Hypersensitivity—Progesterone—uterine cancer	0.00014	0.00139	CcSEcCtD
Exemestane—Neoplasm—Epirubicin—uterine cancer	0.000138	0.00137	CcSEcCtD
Exemestane—Influenza like illness—Doxorubicin—uterine cancer	0.000137	0.00136	CcSEcCtD
Exemestane—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000137	0.00135	CcSEcCtD
Exemestane—Asthenia—Progesterone—uterine cancer	0.000136	0.00135	CcSEcCtD
Exemestane—Hypoaesthesia—Etoposide—uterine cancer	0.000136	0.00135	CcSEcCtD
Exemestane—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.00135	CcSEcCtD
Exemestane—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000136	0.00135	CcSEcCtD
Exemestane—Pruritus—Progesterone—uterine cancer	0.000135	0.00133	CcSEcCtD
Exemestane—Oedema—Dactinomycin—uterine cancer	0.000134	0.00133	CcSEcCtD
Exemestane—Infection—Dactinomycin—uterine cancer	0.000134	0.00132	CcSEcCtD
Exemestane—Neuropathy—Doxorubicin—uterine cancer	0.000133	0.00131	CcSEcCtD
Exemestane—Thrombocytopenia—Dactinomycin—uterine cancer	0.000132	0.0013	CcSEcCtD
Exemestane—Diarrhoea—Progesterone—uterine cancer	0.00013	0.00129	CcSEcCtD
Exemestane—Erythema multiforme—Etoposide—uterine cancer	0.000129	0.00128	CcSEcCtD
Exemestane—Anorexia—Dactinomycin—uterine cancer	0.000128	0.00127	CcSEcCtD
Exemestane—Neoplasm—Doxorubicin—uterine cancer	0.000128	0.00126	CcSEcCtD
Exemestane—Cardiac disorder—Etoposide—uterine cancer	0.000127	0.00126	CcSEcCtD
Exemestane—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000127	0.00126	CcSEcCtD
Exemestane—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000126	0.0266	CbGpPWpGaD
Exemestane—Dizziness—Progesterone—uterine cancer	0.000126	0.00124	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000126	0.0265	CbGpPWpGaD
Exemestane—CYP19A1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000124	0.0262	CbGpPWpGaD
Exemestane—Immune system disorder—Etoposide—uterine cancer	0.000124	0.00122	CcSEcCtD
Exemestane—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000124	0.00122	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000122	0.00121	CcSEcCtD
Exemestane—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000122	0.00121	CcSEcCtD
Exemestane—Alopecia—Etoposide—uterine cancer	0.000121	0.0012	CcSEcCtD
Exemestane—Vomiting—Progesterone—uterine cancer	0.000121	0.0012	CcSEcCtD
Exemestane—Rash—Progesterone—uterine cancer	0.00012	0.00119	CcSEcCtD
Exemestane—Dermatitis—Progesterone—uterine cancer	0.00012	0.00118	CcSEcCtD
Exemestane—Headache—Progesterone—uterine cancer	0.000119	0.00118	CcSEcCtD
Exemestane—Hot flush—Epirubicin—uterine cancer	0.000119	0.00117	CcSEcCtD
Exemestane—Increased appetite—Epirubicin—uterine cancer	0.000118	0.00117	CcSEcCtD
Exemestane—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000118	0.00117	CcSEcCtD
Exemestane—Menopausal symptoms—Epirubicin—uterine cancer	0.000118	0.00116	CcSEcCtD
Exemestane—Decreased appetite—Dactinomycin—uterine cancer	0.000117	0.00116	CcSEcCtD
Exemestane—Fatigue—Dactinomycin—uterine cancer	0.000116	0.00115	CcSEcCtD
Exemestane—Back pain—Etoposide—uterine cancer	0.000115	0.00114	CcSEcCtD
Exemestane—Pain—Dactinomycin—uterine cancer	0.000115	0.00114	CcSEcCtD
Exemestane—Muscle spasms—Etoposide—uterine cancer	0.000115	0.00113	CcSEcCtD
Exemestane—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000114	0.00113	CcSEcCtD
Exemestane—Cardiac failure—Epirubicin—uterine cancer	0.000114	0.00112	CcSEcCtD
Exemestane—Cerebrovascular accident—Epirubicin—uterine cancer	0.000113	0.00112	CcSEcCtD
Exemestane—Nausea—Progesterone—uterine cancer	0.000113	0.00112	CcSEcCtD
Exemestane—Testosterone—CYP19A1—uterine cancer	0.000111	0.0343	CrCbGaD
Exemestane—Pain in extremity—Epirubicin—uterine cancer	0.000111	0.0011	CcSEcCtD
Exemestane—Osteoarthritis—Epirubicin—uterine cancer	0.000111	0.0011	CcSEcCtD
Exemestane—Feeling abnormal—Dactinomycin—uterine cancer	0.000111	0.0011	CcSEcCtD
Exemestane—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00011	0.00109	CcSEcCtD
Exemestane—Hot flush—Doxorubicin—uterine cancer	0.00011	0.00109	CcSEcCtD
Exemestane—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00011	0.00108	CcSEcCtD
Exemestane—Increased appetite—Doxorubicin—uterine cancer	0.000109	0.00108	CcSEcCtD
Exemestane—Menopausal symptoms—Doxorubicin—uterine cancer	0.000109	0.00108	CcSEcCtD
Exemestane—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000109	0.00107	CcSEcCtD
Exemestane—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000109	0.00107	CcSEcCtD
Exemestane—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000108	0.00107	CcSEcCtD
Exemestane—Malaise—Etoposide—uterine cancer	0.000108	0.00106	CcSEcCtD
Exemestane—Leukopenia—Etoposide—uterine cancer	0.000107	0.00106	CcSEcCtD
Exemestane—Abdominal pain—Dactinomycin—uterine cancer	0.000106	0.00105	CcSEcCtD
Exemestane—Body temperature increased—Dactinomycin—uterine cancer	0.000106	0.00105	CcSEcCtD
Exemestane—Cardiac failure—Doxorubicin—uterine cancer	0.000105	0.00104	CcSEcCtD
Exemestane—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000105	0.00104	CcSEcCtD
Exemestane—Cough—Etoposide—uterine cancer	0.000104	0.00103	CcSEcCtD
Exemestane—Hypertension—Etoposide—uterine cancer	0.000103	0.00102	CcSEcCtD
Exemestane—Osteoarthritis—Doxorubicin—uterine cancer	0.000103	0.00102	CcSEcCtD
Exemestane—Pain in extremity—Doxorubicin—uterine cancer	0.000103	0.00102	CcSEcCtD
Exemestane—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000102	0.00101	CcSEcCtD
Exemestane—CYP19A1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000102	0.0216	CbGpPWpGaD
Exemestane—Chest pain—Etoposide—uterine cancer	0.000101	0.001	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000101	0.000997	CcSEcCtD
Exemestane—Hypersensitivity—Dactinomycin—uterine cancer	9.9e-05	0.000979	CcSEcCtD
Exemestane—Confusional state—Etoposide—uterine cancer	9.81e-05	0.00097	CcSEcCtD
Exemestane—Infection—Etoposide—uterine cancer	9.67e-05	0.000956	CcSEcCtD
Exemestane—Asthenia—Dactinomycin—uterine cancer	9.64e-05	0.000954	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1B10—uterine cancer	9.63e-05	0.0203	CbGpPWpGaD
Exemestane—Thrombocytopenia—Etoposide—uterine cancer	9.53e-05	0.000942	CcSEcCtD
Exemestane—Skin disorder—Etoposide—uterine cancer	9.45e-05	0.000934	CcSEcCtD
Exemestane—Hyperhidrosis—Etoposide—uterine cancer	9.41e-05	0.00093	CcSEcCtD
Exemestane—Angina pectoris—Epirubicin—uterine cancer	9.34e-05	0.000924	CcSEcCtD
Exemestane—Anorexia—Etoposide—uterine cancer	9.27e-05	0.000917	CcSEcCtD
Exemestane—Bronchitis—Epirubicin—uterine cancer	9.22e-05	0.000912	CcSEcCtD
Exemestane—Diarrhoea—Dactinomycin—uterine cancer	9.2e-05	0.000909	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1B1—uterine cancer	8.95e-05	0.0189	CbGpPWpGaD
Exemestane—Upper respiratory tract infection—Epirubicin—uterine cancer	8.91e-05	0.000881	CcSEcCtD
Exemestane—Paraesthesia—Etoposide—uterine cancer	8.74e-05	0.000864	CcSEcCtD
Exemestane—Weight increased—Epirubicin—uterine cancer	8.73e-05	0.000863	CcSEcCtD
Exemestane—Dyspnoea—Etoposide—uterine cancer	8.67e-05	0.000858	CcSEcCtD
Exemestane—Angina pectoris—Doxorubicin—uterine cancer	8.64e-05	0.000855	CcSEcCtD
Exemestane—Vomiting—Dactinomycin—uterine cancer	8.55e-05	0.000845	CcSEcCtD
Exemestane—Bronchitis—Doxorubicin—uterine cancer	8.53e-05	0.000844	CcSEcCtD
Exemestane—Rash—Dactinomycin—uterine cancer	8.48e-05	0.000838	CcSEcCtD
Exemestane—Decreased appetite—Etoposide—uterine cancer	8.46e-05	0.000836	CcSEcCtD
Exemestane—Gastrointestinal disorder—Etoposide—uterine cancer	8.4e-05	0.00083	CcSEcCtD
Exemestane—Fatigue—Etoposide—uterine cancer	8.39e-05	0.000829	CcSEcCtD
Exemestane—Neuropathy peripheral—Epirubicin—uterine cancer	8.38e-05	0.000829	CcSEcCtD
Exemestane—Pain—Etoposide—uterine cancer	8.32e-05	0.000823	CcSEcCtD
Exemestane—Constipation—Etoposide—uterine cancer	8.32e-05	0.000823	CcSEcCtD
Exemestane—Urinary tract infection—Epirubicin—uterine cancer	8.31e-05	0.000822	CcSEcCtD
Exemestane—Upper respiratory tract infection—Doxorubicin—uterine cancer	8.25e-05	0.000815	CcSEcCtD
Exemestane—Sweating—Epirubicin—uterine cancer	8.2e-05	0.00081	CcSEcCtD
Exemestane—Hepatobiliary disease—Epirubicin—uterine cancer	8.09e-05	0.0008	CcSEcCtD
Exemestane—Weight increased—Doxorubicin—uterine cancer	8.08e-05	0.000798	CcSEcCtD
Exemestane—Sinusitis—Epirubicin—uterine cancer	8.02e-05	0.000793	CcSEcCtD
Exemestane—Feeling abnormal—Etoposide—uterine cancer	8.02e-05	0.000793	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	8e-05	0.0169	CbGpPWpGaD
Exemestane—Nausea—Dactinomycin—uterine cancer	7.98e-05	0.000789	CcSEcCtD
Exemestane—Gastrointestinal pain—Etoposide—uterine cancer	7.96e-05	0.000787	CcSEcCtD
Exemestane—Neuropathy peripheral—Doxorubicin—uterine cancer	7.76e-05	0.000767	CcSEcCtD
Exemestane—Urticaria—Etoposide—uterine cancer	7.73e-05	0.000764	CcSEcCtD
Exemestane—Haemoglobin—Epirubicin—uterine cancer	7.72e-05	0.000763	CcSEcCtD
Exemestane—Rhinitis—Epirubicin—uterine cancer	7.7e-05	0.000761	CcSEcCtD
Exemestane—Abdominal pain—Etoposide—uterine cancer	7.69e-05	0.00076	CcSEcCtD
Exemestane—Body temperature increased—Etoposide—uterine cancer	7.69e-05	0.00076	CcSEcCtD
Exemestane—Urinary tract infection—Doxorubicin—uterine cancer	7.69e-05	0.00076	CcSEcCtD
Exemestane—Haemorrhage—Epirubicin—uterine cancer	7.68e-05	0.000759	CcSEcCtD
Exemestane—Hepatitis—Epirubicin—uterine cancer	7.68e-05	0.000759	CcSEcCtD
Exemestane—Hypoaesthesia—Epirubicin—uterine cancer	7.64e-05	0.000755	CcSEcCtD
Exemestane—Pharyngitis—Epirubicin—uterine cancer	7.62e-05	0.000753	CcSEcCtD
Exemestane—Sweating—Doxorubicin—uterine cancer	7.59e-05	0.00075	CcSEcCtD
Exemestane—Oedema peripheral—Epirubicin—uterine cancer	7.56e-05	0.000748	CcSEcCtD
Exemestane—Hepatobiliary disease—Doxorubicin—uterine cancer	7.48e-05	0.00074	CcSEcCtD
Exemestane—Sinusitis—Doxorubicin—uterine cancer	7.42e-05	0.000734	CcSEcCtD
Exemestane—Visual impairment—Epirubicin—uterine cancer	7.4e-05	0.000731	CcSEcCtD
Exemestane—Erythema multiforme—Epirubicin—uterine cancer	7.26e-05	0.000718	CcSEcCtD
Exemestane—Hypersensitivity—Etoposide—uterine cancer	7.17e-05	0.000709	CcSEcCtD
Exemestane—Haemoglobin—Doxorubicin—uterine cancer	7.14e-05	0.000706	CcSEcCtD
Exemestane—Cardiac disorder—Epirubicin—uterine cancer	7.12e-05	0.000704	CcSEcCtD
Exemestane—Rhinitis—Doxorubicin—uterine cancer	7.12e-05	0.000704	CcSEcCtD
Exemestane—Haemorrhage—Doxorubicin—uterine cancer	7.1e-05	0.000702	CcSEcCtD
Exemestane—Hepatitis—Doxorubicin—uterine cancer	7.1e-05	0.000702	CcSEcCtD
Exemestane—Hypoaesthesia—Doxorubicin—uterine cancer	7.07e-05	0.000699	CcSEcCtD
Exemestane—Pharyngitis—Doxorubicin—uterine cancer	7.05e-05	0.000697	CcSEcCtD
Exemestane—Oedema peripheral—Doxorubicin—uterine cancer	7e-05	0.000692	CcSEcCtD
Exemestane—Asthenia—Etoposide—uterine cancer	6.98e-05	0.00069	CcSEcCtD
Exemestane—CYP19A1—Ovarian Infertility Genes—CDKN1B—uterine cancer	6.96e-05	0.0147	CbGpPWpGaD
Exemestane—Immune system disorder—Epirubicin—uterine cancer	6.93e-05	0.000686	CcSEcCtD
Exemestane—Pruritus—Etoposide—uterine cancer	6.88e-05	0.000681	CcSEcCtD
Exemestane—Visual impairment—Doxorubicin—uterine cancer	6.84e-05	0.000677	CcSEcCtD
Exemestane—Alopecia—Epirubicin—uterine cancer	6.78e-05	0.000671	CcSEcCtD
Exemestane—Mental disorder—Epirubicin—uterine cancer	6.73e-05	0.000665	CcSEcCtD
Exemestane—Erythema multiforme—Doxorubicin—uterine cancer	6.72e-05	0.000664	CcSEcCtD
Exemestane—Diarrhoea—Etoposide—uterine cancer	6.66e-05	0.000658	CcSEcCtD
Exemestane—Cardiac disorder—Doxorubicin—uterine cancer	6.59e-05	0.000652	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1C1—uterine cancer	6.57e-05	0.0139	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	6.49e-05	0.0137	CbGpPWpGaD
Exemestane—Back pain—Epirubicin—uterine cancer	6.46e-05	0.000639	CcSEcCtD
Exemestane—Dizziness—Etoposide—uterine cancer	6.43e-05	0.000636	CcSEcCtD
Exemestane—Muscle spasms—Epirubicin—uterine cancer	6.42e-05	0.000635	CcSEcCtD
Exemestane—Immune system disorder—Doxorubicin—uterine cancer	6.42e-05	0.000634	CcSEcCtD
Exemestane—Alopecia—Doxorubicin—uterine cancer	6.28e-05	0.000621	CcSEcCtD
Exemestane—Mental disorder—Doxorubicin—uterine cancer	6.22e-05	0.000615	CcSEcCtD
Exemestane—Vomiting—Etoposide—uterine cancer	6.19e-05	0.000612	CcSEcCtD
Exemestane—Rash—Etoposide—uterine cancer	6.13e-05	0.000607	CcSEcCtD
Exemestane—Dermatitis—Etoposide—uterine cancer	6.13e-05	0.000606	CcSEcCtD
Exemestane—Headache—Etoposide—uterine cancer	6.09e-05	0.000603	CcSEcCtD
Exemestane—Malaise—Epirubicin—uterine cancer	6.03e-05	0.000596	CcSEcCtD
Exemestane—Leukopenia—Epirubicin—uterine cancer	5.98e-05	0.000591	CcSEcCtD
Exemestane—Back pain—Doxorubicin—uterine cancer	5.98e-05	0.000591	CcSEcCtD
Exemestane—Muscle spasms—Doxorubicin—uterine cancer	5.94e-05	0.000588	CcSEcCtD
Exemestane—Cough—Epirubicin—uterine cancer	5.83e-05	0.000577	CcSEcCtD
Exemestane—Nausea—Etoposide—uterine cancer	5.78e-05	0.000571	CcSEcCtD
Exemestane—Hypertension—Epirubicin—uterine cancer	5.77e-05	0.00057	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—GPX3—uterine cancer	5.77e-05	0.0122	CbGpPWpGaD
Exemestane—Myalgia—Epirubicin—uterine cancer	5.69e-05	0.000562	CcSEcCtD
Exemestane—Chest pain—Epirubicin—uterine cancer	5.69e-05	0.000562	CcSEcCtD
Exemestane—Arthralgia—Epirubicin—uterine cancer	5.69e-05	0.000562	CcSEcCtD
Exemestane—Anxiety—Epirubicin—uterine cancer	5.67e-05	0.000561	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	5.65e-05	0.000559	CcSEcCtD
Exemestane—Malaise—Doxorubicin—uterine cancer	5.58e-05	0.000551	CcSEcCtD
Exemestane—Leukopenia—Doxorubicin—uterine cancer	5.53e-05	0.000547	CcSEcCtD
Exemestane—Confusional state—Epirubicin—uterine cancer	5.5e-05	0.000544	CcSEcCtD
Exemestane—Oedema—Epirubicin—uterine cancer	5.45e-05	0.000539	CcSEcCtD
Exemestane—CYP19A1—Biological oxidations—CYP11A1—uterine cancer	5.43e-05	0.0115	CbGpPWpGaD
Exemestane—Infection—Epirubicin—uterine cancer	5.42e-05	0.000536	CcSEcCtD
Exemestane—Cough—Doxorubicin—uterine cancer	5.4e-05	0.000533	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—CYP11A1—uterine cancer	5.35e-05	0.0113	CbGpPWpGaD
Exemestane—Nervous system disorder—Epirubicin—uterine cancer	5.35e-05	0.000529	CcSEcCtD
Exemestane—Thrombocytopenia—Epirubicin—uterine cancer	5.34e-05	0.000528	CcSEcCtD
Exemestane—Hypertension—Doxorubicin—uterine cancer	5.34e-05	0.000528	CcSEcCtD
Exemestane—Skin disorder—Epirubicin—uterine cancer	5.3e-05	0.000524	CcSEcCtD
Exemestane—Hyperhidrosis—Epirubicin—uterine cancer	5.27e-05	0.000521	CcSEcCtD
Exemestane—Arthralgia—Doxorubicin—uterine cancer	5.26e-05	0.00052	CcSEcCtD
Exemestane—Chest pain—Doxorubicin—uterine cancer	5.26e-05	0.00052	CcSEcCtD
Exemestane—Myalgia—Doxorubicin—uterine cancer	5.26e-05	0.00052	CcSEcCtD
Exemestane—Anxiety—Doxorubicin—uterine cancer	5.25e-05	0.000519	CcSEcCtD
Exemestane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	5.23e-05	0.000517	CcSEcCtD
Exemestane—Anorexia—Epirubicin—uterine cancer	5.2e-05	0.000514	CcSEcCtD
Exemestane—Confusional state—Doxorubicin—uterine cancer	5.09e-05	0.000503	CcSEcCtD
Exemestane—CYP19A1—Metapathway biotransformation—AKR1C3—uterine cancer	5.06e-05	0.0107	CbGpPWpGaD
Exemestane—Oedema—Doxorubicin—uterine cancer	5.05e-05	0.000499	CcSEcCtD
Exemestane—Infection—Doxorubicin—uterine cancer	5.01e-05	0.000496	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Epirubicin—uterine cancer	4.97e-05	0.000491	CcSEcCtD
Exemestane—Nervous system disorder—Doxorubicin—uterine cancer	4.95e-05	0.000489	CcSEcCtD
Exemestane—Thrombocytopenia—Doxorubicin—uterine cancer	4.94e-05	0.000488	CcSEcCtD
Exemestane—Insomnia—Epirubicin—uterine cancer	4.93e-05	0.000488	CcSEcCtD
Exemestane—Skin disorder—Doxorubicin—uterine cancer	4.9e-05	0.000485	CcSEcCtD
Exemestane—Paraesthesia—Epirubicin—uterine cancer	4.9e-05	0.000484	CcSEcCtD
Exemestane—Hyperhidrosis—Doxorubicin—uterine cancer	4.88e-05	0.000482	CcSEcCtD
Exemestane—Dyspnoea—Epirubicin—uterine cancer	4.86e-05	0.000481	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.82e-05	0.0102	CbGpPWpGaD
Exemestane—Anorexia—Doxorubicin—uterine cancer	4.81e-05	0.000476	CcSEcCtD
Exemestane—Dyspepsia—Epirubicin—uterine cancer	4.8e-05	0.000475	CcSEcCtD
Exemestane—Decreased appetite—Epirubicin—uterine cancer	4.74e-05	0.000469	CcSEcCtD
Exemestane—Gastrointestinal disorder—Epirubicin—uterine cancer	4.71e-05	0.000466	CcSEcCtD
Exemestane—Fatigue—Epirubicin—uterine cancer	4.7e-05	0.000465	CcSEcCtD
Exemestane—Constipation—Epirubicin—uterine cancer	4.66e-05	0.000461	CcSEcCtD
Exemestane—Pain—Epirubicin—uterine cancer	4.66e-05	0.000461	CcSEcCtD
Exemestane—Musculoskeletal discomfort—Doxorubicin—uterine cancer	4.6e-05	0.000455	CcSEcCtD
Exemestane—Insomnia—Doxorubicin—uterine cancer	4.56e-05	0.000451	CcSEcCtD
Exemestane—Paraesthesia—Doxorubicin—uterine cancer	4.53e-05	0.000448	CcSEcCtD
Exemestane—Dyspnoea—Doxorubicin—uterine cancer	4.5e-05	0.000445	CcSEcCtD
Exemestane—Feeling abnormal—Epirubicin—uterine cancer	4.49e-05	0.000444	CcSEcCtD
Exemestane—Gastrointestinal pain—Epirubicin—uterine cancer	4.46e-05	0.000441	CcSEcCtD
Exemestane—Dyspepsia—Doxorubicin—uterine cancer	4.44e-05	0.000439	CcSEcCtD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—STK11—uterine cancer	4.43e-05	0.00935	CbGpPWpGaD
Exemestane—Decreased appetite—Doxorubicin—uterine cancer	4.39e-05	0.000434	CcSEcCtD
Exemestane—Gastrointestinal disorder—Doxorubicin—uterine cancer	4.36e-05	0.000431	CcSEcCtD
Exemestane—Fatigue—Doxorubicin—uterine cancer	4.35e-05	0.00043	CcSEcCtD
Exemestane—Urticaria—Epirubicin—uterine cancer	4.33e-05	0.000428	CcSEcCtD
Exemestane—Constipation—Doxorubicin—uterine cancer	4.32e-05	0.000427	CcSEcCtD
Exemestane—Pain—Doxorubicin—uterine cancer	4.32e-05	0.000427	CcSEcCtD
Exemestane—Body temperature increased—Epirubicin—uterine cancer	4.31e-05	0.000426	CcSEcCtD
Exemestane—Abdominal pain—Epirubicin—uterine cancer	4.31e-05	0.000426	CcSEcCtD
Exemestane—CYP19A1—FSH signaling pathway—AKT1—uterine cancer	4.23e-05	0.00893	CbGpPWpGaD
Exemestane—Feeling abnormal—Doxorubicin—uterine cancer	4.16e-05	0.000411	CcSEcCtD
Exemestane—Gastrointestinal pain—Doxorubicin—uterine cancer	4.13e-05	0.000408	CcSEcCtD
Exemestane—Hypersensitivity—Epirubicin—uterine cancer	4.02e-05	0.000397	CcSEcCtD
Exemestane—Urticaria—Doxorubicin—uterine cancer	4.01e-05	0.000396	CcSEcCtD
Exemestane—Body temperature increased—Doxorubicin—uterine cancer	3.99e-05	0.000394	CcSEcCtD
Exemestane—Abdominal pain—Doxorubicin—uterine cancer	3.99e-05	0.000394	CcSEcCtD
Exemestane—Asthenia—Epirubicin—uterine cancer	3.91e-05	0.000387	CcSEcCtD
Exemestane—Pruritus—Epirubicin—uterine cancer	3.86e-05	0.000381	CcSEcCtD
Exemestane—Diarrhoea—Epirubicin—uterine cancer	3.73e-05	0.000369	CcSEcCtD
Exemestane—Hypersensitivity—Doxorubicin—uterine cancer	3.72e-05	0.000368	CcSEcCtD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	3.68e-05	0.00776	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	3.63e-05	0.00766	CbGpPWpGaD
Exemestane—Asthenia—Doxorubicin—uterine cancer	3.62e-05	0.000358	CcSEcCtD
Exemestane—Dizziness—Epirubicin—uterine cancer	3.61e-05	0.000357	CcSEcCtD
Exemestane—Pruritus—Doxorubicin—uterine cancer	3.57e-05	0.000353	CcSEcCtD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.48e-05	0.00735	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.48e-05	0.00735	CbGpPWpGaD
Exemestane—Vomiting—Epirubicin—uterine cancer	3.47e-05	0.000343	CcSEcCtD
Exemestane—Diarrhoea—Doxorubicin—uterine cancer	3.45e-05	0.000341	CcSEcCtD
Exemestane—Rash—Epirubicin—uterine cancer	3.44e-05	0.00034	CcSEcCtD
Exemestane—Dermatitis—Epirubicin—uterine cancer	3.44e-05	0.00034	CcSEcCtD
Exemestane—Headache—Epirubicin—uterine cancer	3.42e-05	0.000338	CcSEcCtD
Exemestane—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	3.35e-05	0.00706	CbGpPWpGaD
Exemestane—Dizziness—Doxorubicin—uterine cancer	3.34e-05	0.00033	CcSEcCtD
Exemestane—Nausea—Epirubicin—uterine cancer	3.24e-05	0.00032	CcSEcCtD
Exemestane—Vomiting—Doxorubicin—uterine cancer	3.21e-05	0.000317	CcSEcCtD
Exemestane—Rash—Doxorubicin—uterine cancer	3.18e-05	0.000315	CcSEcCtD
Exemestane—Dermatitis—Doxorubicin—uterine cancer	3.18e-05	0.000314	CcSEcCtD
Exemestane—Headache—Doxorubicin—uterine cancer	3.16e-05	0.000313	CcSEcCtD
Exemestane—Nausea—Doxorubicin—uterine cancer	3e-05	0.000296	CcSEcCtD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	2.98e-05	0.00629	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—ESR1—uterine cancer	2.96e-05	0.00625	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	2.81e-05	0.00593	CbGpPWpGaD
Exemestane—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.71e-05	0.00571	CbGpPWpGaD
Exemestane—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.67e-05	0.00563	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	2.61e-05	0.00551	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	2.58e-05	0.00543	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.56e-05	0.00539	CbGpPWpGaD
Exemestane—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.19e-05	0.00463	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—NDUFB11—uterine cancer	2.15e-05	0.00453	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—SRD5A2—uterine cancer	2.15e-05	0.00453	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.08e-05	0.0044	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.97e-05	0.00415	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.92e-05	0.00404	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.9e-05	0.00401	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.85e-05	0.00391	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1.77e-05	0.00373	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	1.68e-05	0.00355	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	1.67e-05	0.00353	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	1.58e-05	0.00334	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	1.56e-05	0.0033	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STAR—uterine cancer	1.55e-05	0.00327	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1B1—uterine cancer	1.55e-05	0.00327	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	1.48e-05	0.00311	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	1.42e-05	0.003	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.26e-05	0.00267	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—POLD1—uterine cancer	1.22e-05	0.00257	CbGpPWpGaD
Exemestane—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.17e-05	0.00246	CbGpPWpGaD
Exemestane—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.15e-05	0.00242	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1C1—uterine cancer	1.14e-05	0.0024	CbGpPWpGaD
Exemestane—CYP19A1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.07e-05	0.00225	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—RRM2—uterine cancer	1.02e-05	0.00214	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—DCN—uterine cancer	9.85e-06	0.00208	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—CYP11A1—uterine cancer	9.28e-06	0.00196	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKR1C3—uterine cancer	8.77e-06	0.00185	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—STK11—uterine cancer	6.83e-06	0.00144	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.41e-06	0.00135	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—SRD5A2—uterine cancer	6.26e-06	0.00132	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—NDUFB11—uterine cancer	6.26e-06	0.00132	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.11e-06	0.00129	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—MTHFR—uterine cancer	5.13e-06	0.00108	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1B1—uterine cancer	4.53e-06	0.000955	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STAR—uterine cancer	4.53e-06	0.000955	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.52e-06	0.000954	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—POLD1—uterine cancer	3.55e-06	0.00075	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C1—uterine cancer	3.32e-06	0.000701	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—RRM2—uterine cancer	2.96e-06	0.000625	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—DCN—uterine cancer	2.88e-06	0.000607	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PTEN—uterine cancer	2.86e-06	0.000602	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—EP300—uterine cancer	2.72e-06	0.000574	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.71e-06	0.000572	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.56e-06	0.00054	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—PIK3CA—uterine cancer	2.01e-06	0.000425	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—STK11—uterine cancer	1.99e-06	0.00042	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.99e-06	0.00042	CbGpPWpGaD
Exemestane—CYP19A1—Metabolism—AKT1—uterine cancer	1.65e-06	0.000347	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—MTHFR—uterine cancer	1.5e-06	0.000316	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PTEN—uterine cancer	8.33e-07	0.000176	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—EP300—uterine cancer	7.95e-07	0.000168	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.88e-07	0.000124	CbGpPWpGaD
Exemestane—CYP3A4—Metabolism—AKT1—uterine cancer	4.8e-07	0.000101	CbGpPWpGaD
